| Literature DB >> 35888657 |
Ioannis Mavroudis1, Ioana-Miruna Balmus2, Alin Ciobica3,4,5, Alina-Costina Luca6, Rumana Chowdhury1, Alin-Constantin Iordache6, Dragos Lucian Gorgan3, Iulian Radu6.
Abstract
Harlequin syndrome (HS) is a rare autonomic disorder. The causes and risk factors of the disease are not fully understood. Some cases of HS are associated with traumatic injuries, tumors, or vascular impairments of the head. Symptoms of HS can also occur in some autoimmune disorders, ophthalmic disorders, sleep disorders, and with certain organic lesions. In this context, a thorough review of the pathophysiology of HS in relation to neurological, ophthalmological, and dermatological conditions is necessary. In this mini-review, we aim to review the pathophysiological changes and underlying mechanisms in primary and secondary HS. Additionally, we discuss possible management approaches for patients with HS in light of the discussed pathological mechanisms. The main symptoms of HS that are correlated with autonomic nervous system impairments include sudden unilateral flushing of the face, neck, chest, and rarely arm, with concurrent contralateral anhidrosis. Despite reported co-occurring syndromes (such as cluster headaches), several studies have shown that HS could frequently overlap with other syndromes that are disruptive to the idiopathic nerve pathways. HS usually does not require any medical treatment. In some severe cases, symptomatic treatments could be needed. However, total symptomatic relief may not be achieved in many cases of HS. We therefore suggest an approach to comprehensive management of HS, which may lead to better long-term control of HS.Entities:
Keywords: Harlequin syndrome; anhidrosis; autonomic nervous system impairment; face flushing; iatrogenic; idiopathic; neurovascular; sweating; sympathetic; unilateral
Mesh:
Year: 2022 PMID: 35888657 PMCID: PMC9324885 DOI: 10.3390/medicina58070938
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.948
Most common causes of secondary Harlequin syndrome (as summarized by all the described cases).
| Organic/Structural Causes | Iatrogenic Causes |
|---|---|
| Cervical syrinx | Paravertebral thoracic block |
| Intermedullary astrocytoma | Jugular vein catheterization |
| Stroke/infract, Diabetic neuropathy | Neck mass resection, including thyroid goiter |
| Thoracic neurofibroma | Thoracic sympathectomy |
| Pancoast tumor | Neuropraxia |
| Compression of sympathetic chain by elongated thyroid artery | Pharmacological causes |
| Small fiber neuropathy/Pure autonomic failure/Unspecified dysautonomia | Cage fusion and additional anterior interbody spondylodesis for cervical radiculopathy |
| Carotid artery dissection |
|
| Mediastinal neurinoma | Discoid lupus erythematosus |
| Guillain–Barré syndrome | Trigeminal neuralgia |
| Brachial plexopathy, Multiple system atrophy | Idiopathic bladder dysfunction (unidentified lower spinal cord lesion) |
Assessment and management of Harlequin syndrome.
| History | History including past medical and family medical history; |
| Physical examination | Neurological examination including tendon reflexes and pupils reaction; |
| Imaging | MRI brain and cervical-thalamic spine including the area of thoracic sympathetic chain, chest X-ray, and thyroid ultrasound; |
| Other investigations | Nerve conduction studies, cardiovascular reflex test, microneurography from peroneal nerve, skin biopsy; |
| Management | Surgical sympathectomy ipsilateral to the affected side, stellate ganglion block, Botulinum toxin. |